- Home
- ACHV vs ARL Comparison
ACHV vs ARL Comparison
Compare ACHV & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHV | ARL |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.7M | 279.4M |
| IPO Year | 2018 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ACHV | ARL |
|---|---|---|
| Price | $4.75 | $17.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 464.6K | 2.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.33 | N/A |
| EPS | N/A | ★ 0.37 |
| Revenue | N/A | ★ $47,318,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $47.54 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.84 | $9.43 |
| 52 Week High | $6.03 | $20.00 |
Technical Indicators
Market Signals| Indicator | ACHV | ARL |
|---|---|---|
| Relative Strength Index (RSI) | 57.34 | 61.01 |
| Support Level | $4.65 | $15.05 |
| Resistance Level | $5.30 | $20.00 |
| Average True Range (ATR) | 0.24 | 0.26 |
| MACD | 0.07 | -0.03 |
| Stochastic Oscillator | 99.37 | 77.22 |
Price Performance
Historical ComparisonAbout ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About ARL American Realty Investors Inc.
American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.